Gilgamesh Pharma Inc.

Other New York, NY

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Other
Headquarters
New York, NY
Street
113 University Place, Suite 1019
Zip
10003

Offering

Total offering
$60M
Amount sold
$60M
First sale
Mar 9, 2026
Min investment
$50k
Securities
Equity, Other
Federal exemption
Rule 506(b)
Investors so far
40

How this filing compares

Ranked #18 of 222 Other filings in March 2026 by offering amount.

Median Other filing in March 2026: $5.4M. This offering is 11.1× the median.

Other New York filings this week: AIM Investors Employee LP, AIM Investors Employee Offshore LP, ASports Private Investors, LLC, Averill Partners, LP, Banyan Tree Capital Partners, L.P.

Leadership

Jonathan Sporn — Executive Officer (also: Director)

Andrew Kruegel — Executive Officer (also: Director)

Zia Huque — Director

Amy Kruse — Director

Robert Berman — Director

Phil Skolnick — Director

Filing details

Gilgamesh Pharma Inc. filed a Form D with the SEC on March 24, 2026.

Other newest Other companies

Other newest companies in New York